Biomedical research at Oslo University Hospital

Oslo University Hospital is a merger of three former university hospitals in Oslo. Biomedical research is one of the hospital's core activities. Research at the hospital is closely interlinked with research undertaken at the University of Oslo. More than 50% of all biomedical research in Norway is published by researchers affiliated with the hospital. Research undertaken cover both basic research, translational research, and clinical research.

Oslo University Hospital has a central role in developing and supporting biomedical research within the South-Eastern Regional Health Authority. The hospital also pursues international research collaborations.

Click here to see hierarchical division and subunit overview

Summary of publications:

Publications (original articles or review articles) published in 2019 from OUS - Department of Cardiology B (Div Med)

33 publications found

Agewall S (2019)
EHJ Cardiovascular Pharmacotherapy has Impact Factor
Eur Heart J, 40 (7), 572
DOI 10.1093/eurheartj/ehy897, PubMed 30768210

Agewall S (2019)
Unsolved issues in oral anticoagulation treatment in atrial fibrillation
Eur Heart J Cardiovasc Pharmacother, 5 (2), 60-61
DOI 10.1093/ehjcvp/pvz008, PubMed 30874812

Agewall S (2019)
European Heart Journal - Cardiovascular Pharmacotherapy: now accepted for an official Impact Factor
Eur Heart J Cardiovasc Pharmacother, 5 (2), 59
DOI 10.1093/ehjcvp/pvz009, PubMed 30874813

Atar D (2019)
Editor's Note
Cardiology, 142 (1), 1 (in press)
DOI 10.1159/000497089, PubMed 30852568

Atar D, Grundvold I (2019)
On-label reduced doses of non-vitamin K anticoagulants prove safe and efficient; yet how to ensure the correct dose for the right patient?
Eur Heart J (in press)
DOI 10.1093/eurheartj/ehz014, PubMed 30753396

Borer JS, Atar D, Marciniak T, Kim MH, Serebruany V (2019)
Atrial Fibrillation and Stroke in Patients with Hypertrophic Cardiomyopathy: Important New Insights
Thromb Haemost, 119 (3), 355-357
DOI 10.1055/s-0039-1678724, PubMed 30759487

Chin KL, Ofori-Asenso R, Hopper I, von Lueder TG, Reid CM, Zoungas S, Wang BH, Liew D (2019)
Potential mechanisms underlying the cardiovascular benefits of sodium glucose cotransporter 2 inhibitors: a systematic review of data from preclinical studies
Cardiovasc Res, 115 (2), 266-276
DOI 10.1093/cvr/cvy295, PubMed 30475996

Dahl Aarvik M, Sandven I, Dondo TB, Gale CP, Ruddox V, Munkhaugen J, Atar D, Otterstad JE (2019)
Effect of oral β-blocker treatment on mortality in contemporary post-myocardial infarction patients: a systematic review and meta-analysis
Eur Heart J Cardiovasc Pharmacother, 5 (1), 12-20
DOI 10.1093/ehjcvp/pvy034, PubMed 30192930

Egan BM, Kjeldsen SE, Grassi G, Esler M, Mancia G (2019)
The global burden of hypertension exceeds 1.4 billion people: should a systolic blood pressure target below 130 become the universal standard?
J Hypertens (in press)
DOI 10.1097/HJH.0000000000002021, PubMed 30624370

Fröhlich H, Rosenfeld N, Täger T, Goode K, Kazmi S, Hole T, Katus HA, Atar D, Cleland JGF, Agewall S, Clark AL, Frankenstein L, Grundtvig M (2019)
Epidemiology and long-term outcome in outpatients with chronic heart failure in Northwestern Europe
Heart (in press)
DOI 10.1136/heartjnl-2018-314256, PubMed 30792238

Hill JA, Agewall S, Baranchuk A, Booz GW, Borer JS, Camici PG, Chen PS, Dominiczak AF, Erol Ç, Grines CL, Gropler R, Guzik TJ, Heinemann MK, Iskandrian AE, Knight BP, London B, Lüscher TF, Metra M, Musunuru K, Nallamothu BK, Natale A, Saksena S, Picard MH, Rao SV, Remme WJ et al. (2019)
Medical misinformation: vet the message!
Cardiovasc Res (in press)
DOI 10.1093/cvr/cvz007, PubMed 30689762

Hill JA, Agewall S, Baranchuk A, Booz GW, Borer JS, Camici PG, Chen PS, Dominiczak AF, Erol Ç, Grines CL, Gropler R, Guzik TJ, Heinemann MK, Iskandrian AE, Knight BP, London B, Lüscher TF, Metra M, Musunuru K, Nallamothu BK, Natale A, Saksena S, Picard MH, Rao SV, Remme WJ et al. (2019)
Medical misinformation: vet the message!
Eur Heart J Cardiovasc Pharmacother, 5 (2), 62-63
DOI 10.1093/ehjcvp/pvz001, PubMed 30689786

Hill JA, Agewall S, Baranchuk A, Booz GW, Borer JS, Camici PG, Chen PS, Dominiczak AF, Erol Ç, Grines CL, Gropler R, Guzik TJ, Heinemann MK, Iskandrian AE, Knight BP, London B, Lüscher TF, Metra M, Musunuru K, Nallamothu BK, Natale A, Saksena S, Picard MH, Rao SV, Remme WJ et al. (2019)
Medical misinformation: vet the message!
Eur Heart J Qual Care Clin Outcomes (in press)
DOI 10.1093/ehjqcco/qcy057, PubMed 30689789

Hill JA, Agewall S, Baranchuk A, Booz GW, Borer JS, Camici PG, Chen PS, Dominiczak AF, Erol Ç, Grines CL, Gropler R, Guzik TJ, Heinemann MK, Iskandrian AE, Knight BP, London B, Lüscher TF, Metra M, Musunuru K, Nallamothu BK, Natale A, Saksena S, Picard MH, Rao SV, Remme WJ et al. (2019)
Medical Misinformation: Vet the Message!
J Cardiovasc Pharmacol, 73 (2), 61-62
DOI 10.1097/FJC.0000000000000648, PubMed 30730472

Hohnloser SH, Fudim M, Alexander JH, Wojdyla DM, Ezekowitz JA, Hanna M, Atar D, Hijazi Z, Bahit MC, Al-Khatib SM, Lopez-Sendon JL, Wallentin L, Granger CB, Lopes RD (2019)
Efficacy and Safety of Apixaban versus Warfarin in Patients with Atrial Fibrillation and Extremes in Body Weight: Insights from the ARISTOTLE Trial
Circulation (in press)
DOI 10.1161/CIRCULATIONAHA.118.037955, PubMed 30773022

Holte KB, Svanteson M, Hanssen KF, Haig Y, Solheim S, Berg TJ (2019)
Undiagnosed coronary artery disease in long-term type 1 diabetes. The Dialong study
J Diabetes Complications (in press)
DOI 10.1016/j.jdiacomp.2019.01.006, PubMed 30846232

Kjeldsen SE, Atar D, von Lueder TG (2019)
Angiotensin receptor neprilysin inhibition for the treatment of hypertension: the neglected child in cardiovascular pharmacotherapy
Eur Heart J Cardiovasc Pharmacother, 5 (2), 122-123
DOI 10.1093/ehjcvp/pvz005, PubMed 30698668

Kjeldsen SE, Mancia G (2019)
Unattended automated office vs. ambulatory blood pressure in people with high cardiovascular risk: implications for understanding the SPRINT results
J Hypertens, 37 (1), 6-8
DOI 10.1097/HJH.0000000000001874, PubMed 30499916

Kjeldsen SE, Narkiewicz K, Burnier M, Oparil S (2019)
Will we ever use angiotensin receptor neprilysin inhibition (ARNi) for the treatment of hypertension?
Blood Press, 28 (2), 75-76
DOI 10.1080/08037051.2019.1584975, PubMed 30806086

Lip GYH, Collet JP, Haude M, Byrne R, Chung EH, Fauchier L, Halvorsen S, Lau D, Lopez-Cabanillas N, Lettino M, Marin F, Obel I, Rubboli A, Storey RF, Valgimigli M, Huber K, ESC Scientific Document Group (2019)
2018 Joint European consensus document on the management of antithrombotic therapy in atrial fibrillation patients presenting with acute coronary syndrome and/or undergoing percutaneous cardiovascular interventions: a joint consensus document of the European Heart Rhythm Association (EHRA), European Society of Cardiology Working Group on Thrombosis, European Association of Percutaneous Cardiovascular Interventions (EAPCI), and European Association of Acute Cardiac Care (ACCA) endorsed by the Heart Rhythm Society (HRS), Asia-Pacific Heart Rhythm Society (APHRS), Latin America Heart Rhythm Society (LAHRS), and Cardiac Arrhythmia Society of Southern Africa (CASSA)
Europace, 21 (2), 192-193
DOI 10.1093/europace/euy174, PubMed 30052888

Mehlum MH, Liestøl K, Wyller TB, Hua TA, Rostrup M, Berge E (2019)
Blood pressure variability in hypertensive patients with atrial fibrillation in the VALUE trial
Blood Press, 28 (2), 77-83
DOI 10.1080/08037051.2018.1524707, PubMed 30614275

Navarese EP, Andreotti F, Raggi P, Kolodziejczak M, Buffon A, Bliden K, Tantry U, Kubica J, Sardella G, Lauten A, Agewall S, Gurbel PA, Brouwer MA (2019)
Baseline low-density lipoprotein cholesterol to predict the extent of cardiovascular benefit from lipid-lowering therapies: a review
Eur Heart J Cardiovasc Pharmacother, 5 (1), 47-54
DOI 10.1093/ehjcvp/pvy038, PubMed 30247574

Opstad TB, Kalstad AA, Pettersen AÅ, Arnesen H, Seljeflot I (2019)
Novel biomolecules of ageing, sex differences and potential underlying mechanisms of telomere shortening in coronary artery disease
Exp Gerontol, 119, 53-60
DOI 10.1016/j.exger.2019.01.020, PubMed 30684534

Piira A, Lannem AM, Sørensen M, Glott T, Knutsen R, Jørgensen L, Gjesdal K, Hjeltnes N, Knutsen SF (2019)
Manually assisted body-weight supported locomotor training does not re-establish walking in non-walking subjects with chronic incomplete spinal cord injury: A randomized clinical trial
J Rehabil Med, 51 (2), 113-119
DOI 10.2340/16501977-2508, PubMed 30483724

Rosano GMC, Spoletini I, Agewall S (2019)
Pharmacology of new treatments for hyperkalaemia: patiromer and sodium zirconium cyclosilicate
Eur Heart J Suppl, 21 (Suppl A), A28-A33
DOI 10.1093/eurheartj/suy035, PubMed 30837802

Salam A, Atkins E, Sundström J, Hirakawa Y, Ettehad D, Emdin C, Neal B, Woodward M, Chalmers J, Berge E, Yusuf S, Rahimi K, Rodgers A, Blood Pressure Lowering Treatment Trialists’ Collaboration (2019)
Effects of blood pressure lowering on cardiovascular events, in the context of regression to the mean: a systematic review of randomized trials
J Hypertens, 37 (1), 16-23
DOI 10.1097/HJH.0000000000001994, PubMed 30499920

Solberg OG, Stavem K, Ragnarsson A, Beitnes JO, Skårdal R, Seljeflot I, Ueland T, Aukrust P, Gullestad L, Aaberge L (2019)
Index of microvascular resistance to assess the effect of rosuvastatin on microvascular function in women with chest pain and no obstructive coronary artery disease: A double-blind randomized study
Catheter Cardiovasc Interv (in press)
DOI 10.1002/ccd.28157, PubMed 30790446

Steen T, Sciaraffia E, Normand C, Bogale N, Dickstein K, Linde C, Philbert BT (2019)
Contemporary practice of CRT implantation in scandinavia compared to Europe
Scand Cardiovasc J, 1-5 (in press)
DOI 10.1080/14017431.2019.1583364, PubMed 30761919

Stokke IM, Li ZB, Cicala S, Okin PM, Kjeldsen SE, Devereux RB, Wachtell K (2019)
Association of left bundle branch block with new onset abnormal wall motion in treated hypertensive patients with left ventricle hypertrophy: the LIFE Echo Sub-study
Blood Press, 28 (2), 84-92
DOI 10.1080/08037051.2019.1569463, PubMed 30698038

Stubnova V, Os I, Høieggen A, Solbu MD, Grundtvig M, Westheim AS, Atar D, Waldum-Grevbo B (2019)
Gender differences in association between uric acid and all-cause mortality in patients with chronic heart failure
BMC Cardiovasc Disord, 19 (1), 4
DOI 10.1186/s12872-018-0989-8, PubMed 30611196

Täger T, Fröhlich H, Grundtvig M, Seiz M, Schellberg D, Goode K, Kazmi S, Hole T, Katus HA, Atar D, Cleland JGF, Agewall S, Clark AL, Frankenstein L (2019)
Comparative effectiveness of loop diuretics on mortality in the treatment of patients with chronic heart failure - A multicenter propensity score matched analysis
Int J Cardiol (in press)
DOI 10.1016/j.ijcard.2019.01.109, PubMed 30827731

Williams B, Mancia G, Spiering W, Rosei EA, Azizi M, Burnier M, Clement DL, Coca A, de Simone G, Dominiczak A, Kahan T, Mahfoud F, Redon J, Ruilope L, Zanchetti A, Kerins M, Kjeldsen SE, Kreutz R, Laurent S, Lip GYH, McManus R, Narkiewicz K, Ruschitzka F, Schmieder RE, Shlyakhto E et al. (2019)
[2018 ESC/ESH Guidelines for the management of arterial hypertension]
Kardiol Pol, 77 (2), 71-159
DOI 10.5603/KP.2019.0018, PubMed 30816983

Aamodt IT, Lycholip E, Celutkiene J, Strömberg A, Atar D, Falk RS, von Lueder T, Hellesø R, Jaarsma T, Lie I (2019)
Health Care Professionals' Perceptions of Home Telemonitoring in Heart Failure Care: Cross-Sectional Survey
J Med Internet Res, 21 (2), e10362
DOI 10.2196/10362, PubMed 30724744

 
Page visits: 113661